Diagnostic significance of prostate-specific antigen velocity at intermediate PSA serum levels in relation to the standard deviation of different test systems

Urologia Internationalis

Volumn 60, Issue 1, 1998, Pages 25-27

  Manseck, A ^a   Pilarsky, C ^a   Froschermaier, S ^a   Menschikowski, M ^a   Wirth, M P ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Benign prostatic hyperplasia; Carcinoma, prostate; Digital rectal examination; Prostate specific antigen; Prostate specific antigen, assay reliability

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL EXAMINATION; CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; RELIABILITY;

ADULT; AGED; BIOLOGICAL ASSAY; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; MIDDLE AGED; PALPATION; PHYSICAL EXAMINATION; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0031953053     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030198     Document Type: Article

References (7)

1. Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJJ, Petros JA, Andriole GL: Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 1991;324:1156-1161.
2. Catalona WJ, Smith DS, Ratliff TL, Basler JW: Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA 1993;270:948-954.
3. Cooner WH, Mosley BR, Rutherford CL, Beard JH, Pond HS, Terry WM, Igel TC, Kidd DD: Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J Urol 1990;143:1146-1154.
4. Oesterling JE, Jacobsen SJ, Chute CG, Guess HA, Girman CJ, Panser LA, Lieber MM: Serum prostate specific antigen in a community-based population of healthy men. JAMA 1993;270:860-864.
5. Carter HB, Pearson JD, Metter EJ, Brant LJ, Chan DW, Andes R, Fozard JL, Walsh PC: Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 1992;267:2215-2220.
6. Wirth MP, Frohmüller HGW: Prostate-specific antigen and prostate acid phosphatase in the detection of early prostate cancer and the prediction of regional lymph node métastases. Eur Urol 1992;22:27-32.
7. Stamey TA, Prestigiacomo A, Komatsu K: Physiological variation of serum prostate specific antigen (PSA) from a screening population in the range of 4-10 ng/ml using the Hybritech Tandem-R PSA assay. J Urol 1995;153(suppl):420A.